http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013202011-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b97c948c84a801e5cad5634c3a536c77 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
filingDate | 2013-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_790246d0be6404f8b300f8e1eb115ea2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc184f88d82ff98d033ce4e147e32677 |
publicationDate | 2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2013202011-C1 |
titleOfInvention | In vivo temporal control of activatable matrix-degrading enzymes |
abstract | Methods and combinations are provided for controlling the duration of action, in vivo, of matrix-degrading enzymes. The methods and combinations permit temporary in-vivo activation of matrix-degrading enzymes upon administration to the extra cellular matrix (or "ECM"). Matrix-degrading enzymes having a controlled duration of action can be used to treat ECM-mediated diseases or disorders characterized by increased deposition or accumulation of one or more ECM components. |
priorityDate | 2008-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2735.